Quantum Biopharma annual net debt
2019
2020
2021
2022
2023
2024
2025
Quantum Biopharma Net Debt Growth & History (QNTM)
Quantum Biopharma's net debt was −$501,643 for fiscal 2025.
View full Quantum Biopharma company overviewQuantum Biopharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$501,643 | $4.8M | — |
| 2024 | 2024-12-31 | −$5.3M | −$2.6M | — |
| 2023 | 2023-12-31 | −$2.7M | $14.0M | — |
| 2022 | 2022-12-31 | −$16.8M | $18.2M | — |
| 2021 | 2021-12-31 | −$35.0M | −$17.6M | — |
| 2020 | 2020-12-31 | −$17.4M | −$11.6M | — |
| 2019 | 2019-12-31 | −$5.8M | — | — |
Quantum Biopharma quarterly net debt
Q4.20
Q4.21
Q4.22
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.7M | −$3.3M | — |
| Q1 2026 | 2026-03-31 | −$3.5M | −$1.1M | — |
| Q4 2025 | 2025-12-31 | −$501,643 | $4.8M | — |
| Q3 2025 | 2025-09-30 | $1.7M | $4.7M | — |
| Q2 2025 | 2025-06-30 | $603,489 | $3.9M | — |
| Q1 2025 | 2025-03-31 | −$2.4M | — | — |
| Q4 2024 | 2024-12-31 | −$5.3M | −$2.6M | — |
| Q3 2024 | 2024-09-30 | −$3.0M | — | — |
| Q2 2024 | 2024-06-30 | −$3.3M | — | — |
| Q4 2023 | 2023-12-31 | −$2.7M | $14.0M | — |
| Q4 2022 | 2022-12-31 | −$16.8M | $18.2M | — |
| Q4 2021 | 2021-12-31 | −$35.0M | −$17.6M | — |
| Q4 2020 | 2020-12-31 | −$17.4M | — | — |
Quantum Biopharma net debt trends
Over the last five fiscal years, Quantum Biopharma's net debt increased from −$17.4M to −$501,643, a change of $16.9M. The latest reported quarter, Q2 2026, shows −$2.7M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quantum Biopharma source filings ↗